Global Outlook 2024 Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Stanley Capital Partners acquires Drug Safety Solutions from Astorg and Nordic Capital-backed Clario

Stanley Capital Partners (SCP), a European and US-focused mid-market private equity firm, has acquired Drug Safety and Pharmacovigilance Services Solutions (DSS), aglobal provider of pharmacovigilance (PV), from Clario.

Stanley Capital Partners (SCP), a European and US-focused mid-market private equity firm, has acquired Drug Safety and Pharmacovigilance Services Solutions (DSS), aglobal provider of pharmacovigilance (PV), from Clario.

Financial terms of the transaction have not been disclosed.
 
DSS is a specialist in providing outsourced services to support clinical safety and pharmacovigilance commitments. 

Rothschild & Co served as financial advisor to Clario. Robert W. Baird & Co. acted as the financial advisor to SCP.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured